Genetic dissection of diabetes: Facing the giant

Diabetes

Volumn 62, Issue 10, 2013, Pages 3338-3340

  Meyre, David ^a   Pare, Guillaume ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ANTIPORTER; CDKAL1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR 2A; IGF2BP2 PROTEIN, HUMAN; RNA BINDING PROTEIN; SLC26A9 PROTEIN, HUMAN;

CAUCASIAN; CYSTIC FIBROSIS; DIABETES MELLITUS; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SCREENING; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUNG FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SWEAT TEST; FEMALE; MALE;

ANTIPORTERS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS;

EID: 84891519846     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1154     Document Type: Note

References (20)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073
2. Ratjen F, Döring G. Cystic fibrosis. Lancet 2003;361:681-689
3. Mishra A, Greaves R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005;26: 135-153
4. Langfelder-Schwind E, Kloza E, Sugarman E, et al.; National Society of Genetic Counselors Subcommittee on Cystic Fibrosis Carrier Testing. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Couns 2005;14:1-15
5. Kelly A, Moran A. Update on cystic fibrosis-related diabetes. J Cyst Fibros 2013;12:318-331
6. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32:1626-1631
7. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162:891-895
8. Koch C, Rainisio M, Madessani U, et al.; Investigators of the European Epidemiologic Registry of Cystic Fibrosis. Presence of cystic fibrosisrelated diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-350
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 2013;36(Suppl. 1):S67-S74
10. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991;118:715-723
11. Lanng S, Thorsteinsson B, Røder ME, et al. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993;128:207-214
12. Mohan V, Alagappan V, Snehalatha C, Ramachandran A, Thiruvengadam KV, Viswanathan M. Insulin and C-peptide responses to glucose load in cystic fibrosis. Diabete Metab 1985;11:376-379
13. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and β-cell dysfunction. Diabet Med 2002;19:221-226
14. Blackman SM, Hsu S, Vanscoy LL, et al. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis. J Clin Endocrinol Metab 2009;94:1302-1309
15. Blackman SM, Commander CW, Watson C, et al. Genetic modifiers of cystic fibrosis-related diabetes. Diabetes 2013;62:3627-3635
16. Khoury MJ, Little J, Gwinn M, Ioannidis JP. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 2007;36:439-445
17. Loriol C, Dulong S, Avella M, et al. Characterization of SLC26A9, facilitation of Cl(-) transport by bicarbonate. Cell Physiol Biochem 2008;22: 15-30
18. Bertrand CA, Zhang R, Pilewski JM, Frizzell RA. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 2009;133:421-438
19. Blackman SM, Hsu S, Ritter SE, et al. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009;52:1858-1865
20. Manolio TA. Bringing genome-wide association findings into clinical use. Nat Rev Genet 2013;14:549-558